The fasting hyperinsulinaemia characteristic of obesity is due to pancreatic hypersecretion and is accompanied by a corresponding increase in plasma C-peptide concentrations. The exaggerated plasma insulin and C-peptide responses to oral glucose in obese subjects which is greater for insulin than C-peptide suggests that the stimulated hyperinsulinaemia is due to both pancreatic hypersecretion and decreased fractional hepatic extraction of insulin. In obese subjects fasting and stimulated insulin concentrations, but not those ofC-peptide, are lower after 3 weeks ofenergy restriction than before it. This reduction in fasting and stimulated insulin levels is, therefore, due to an increase in the fractional extraction of insulin by the liver rather than to a reduction in pancreatic secretion as had previously been supposed.
Hyperinsulinaemia is characteristic of obesity. Obese subjects have both elevated fasting insulin concentrations and exaggerated plasma insulin responses to insulinotrophic stimuli, such as oral glucose, when compared with normal weight controls. I·" Obese subjects are also insulin insensitive and this is due to a combination of decreased insulin receptors and post-receptor defects.' It has also been suggested, although not proven," that in obese subjects there is in addition to pancreatic overproduction of insulin 3 ,6.7 a decrease in its fractional hepatic extraction.v"
Insulin and C-peptide are secreted in equimolar amounts.'! C-peptide, however, unlike insulin is not extracted from the portal blood by the liver.P:" Consequently C-peptide concentrations in peripheral blood are now considered to provide a more reliable indication of pancreatic B-cell secretion than peripheral insulin concentrations which reflect the balance between insulin secretion and its extraction from the portal blood by the liver.
As part of a study into the metabolic and endocrine consequences of feeding obese patients with very low energy diets (VLCD) we measured 388 plasma insulin and C-peptide concentrations collected during fasting and in response to oral glucose before and after 3 weeks of caloric restriction. The results of this study are reported here.
Subjects and methods
The clinical characteristics of the seven obese patients recruited from the metabolic clinic at St Luke's Hospital, Guildford and the seven normal weight age-matched healthy volunteers who served as their controls are shown in Table I . None of the obese subjects was diabetic nor did any have evidence of hepatic, renal, thyroid or any other somatic disease. None was receiving any medication nor had altered their diet or weight in the previous month. All subjects gave their informed consent to participate in this study which was approved by the ethical committee of St Luke's and Royal Surrey County Hospitals.
After an overnight fast, the subjects were given 75 gof oral liquid glucose supplied as starch hydrolysate (Hycal, Beechams, Brentford, UK) diluted to 220 mL with water. Blood was collected from an indwelling antecubital intravenous canula at 0,30,60,90, 120, ISO, 180,240 and 300 min. Plasma was separated immediately and either analysed for glucose or stored frozen at 
Results
After 3 weeks treatment with the VLCD the obese patients lost 5·1 ± 0·9 kg (3-10 kg) in weight which corresponds to a decrease of 4·7 ±0·9% (3,0-9,7) on their initial body weight.
Fasting and stimulated plasma glucose, immunoreactive insulin and C-peptide concentrations are shown in Fig. I and Table 2 . Fasting plasma glucose concentrations were similar in the control, untreated obese and treated obese groups. Integrated plasma glucose concentrations were higher (P < 0'02) in the obese subjects than controls and did not change following energy restriction. Fasting immunoreactive insulin concentrations and their integrated responses to glucose were higher (P < 0,05) in the obese subjects than controls and fell (P < 0,05) after caloric restriction. Fasting and integrated immunoreactive Cpeptide concentrations were higher (P<0·02) in the obese subjects than controls but were unal-Results are mean + SEM.
8MI is the body mass index (weight/height-), -20°C until assayed, within 4 weeks, for immunoreactive insulin and C-peptide. Our assays show no deterioration in measured insulin and Cpeptide concentrations in specimens stored at -20°C. The procedure was repeated in the obese subjects after 3 weeks treatment with a VLCD. Plasma creatinine was measured in the fasting samples. Plasma glucose and creatinine were measured by automated glucose-oxidase and Jaffe reaction methods respectively. Plasma insulin and C-peptide were measured by radioimmunoassay" using antisera supplied by Guildhay Antisera, Guildford, Surrey, UK. The inter-assay and intra-assay coefficients of variation for glucose were 2·0 and 1·6% respectively, insulin 7·4 and 5·5% respectively and C-peptide 9·0 and 5·7% respectively.
The low energy diet consisted of one sachet of Modifast (Wander Limited, Station Road, Kings Langley, Herts, UK) dissolved in 300 mL ofwater consumed three times a day at regular meal times. The patients were advised to drink a further 2 L of water each day. The diet provided 445 kcal (1891 kJ) per day and contained 50 g of protein, 45 g of carbohydrate, 7·2 g of fat, vitamins and minerals.
Fasting and integrated insulin: C-peptide molar ratios were used to reflect fractional hepatic extraction of insulin. Peripheral C-peptide levels as markers of pancreatic secretion are only valid in the steady state. 16 Therefore as fasting is a steady state and provided that after stimulation insulin and C-peptide concentrations return to their steady state levels the fasting and integrated insulin: C-peptide molar ratios reflect hepatic insulin extraction.
Student's unpaired r-test was used to compare the significance ofdifferences between groups and Student's paired t-test to make comparisons within the same group. P values of < 0·05 were accepted as statistically significant. Integrated responses were calculated using the linear trapezoid rule. Results are expressed as mean ±standard error of the mean (SEM).
Control
Obese tered by energy restriction. In the untreated obese subjects neither the fasting or integrated insulin: C-peptide molar ratios differed from those of the normal weight controls, but both fell (P < 0·05 and P < 0·02 respectively) after treatment with the VLCD. Plasma creatinine concentrations were similar before (90,6 ± 3·1 J.lmolJL) and after (92,4 ±2·9 J.lmolJL) energy restriction.
Discussion
This study confirms both the fasting hyperinsulinaemia and the exaggerated insulin responses to oral glucose associated with obesity. 1-4 The longstanding assumption that the hyperinsulinaemia is solely due to increased pancreatic secretion'? has been questioned by some investigators":" on the basis ofa disparity between peripheral plasma C-peptide and insulin levels. In comparison to normal weight controls, the higher fasting and stimulated plasma insulin and C-peptide concentrations in the untreated obese patients confirm pancreatic hypersecretion as a cause for the fasting and stimulated hyperinsulinaemia of obesity. The greater insulinaemic than C-peptide response to oral glucose in obese subjects suggests that decreased hepatic extraction of insulin may also contribute to the stimulated hyperinsulinaernia of obesity. These results are compatible with those of Faber and co-workers" but only partly with those of others who have suggested that decreased hepatic extraction of insulin contributes even to the fasting hyperinsulinaemia? or accounts entirely for the exaggerated response to oral glucose. II In this study renal function was unaltered and therefore the unchanged peripheral C-peptide concentrations following energy restriction suggest continued pancreatic hypersecretion. The decrease in fasting insulin concentrations and the attenuated insulinaemic response to oral glucose after short-term calorie restriction and weight loss was, therefore, probably due to increased fractional extraction of insulin by the liver. An alternative explanation is that alterations in proinsulin concentrations could be responsible for the changes in immunoreactive insulin levels in view of the fact that our insulin radioimmunoassay cross-reacts with proinsulin to the extent of 100%. In obese subjects, however, proinsulin accounts for 30% and 15% of the fasted and stimulated peripheral immunoreactive insulin concentrations respectively," and moreover only a small amount of proinsulin is removed from the portal circulation by the liver." A decrease in proinsulin could, therefore, not account for but could contribute to the reduction in the circulating immunoreactive insulin concentrations following energy restriction.
Jimenez and co-workers'" have shown that massive weight loss in surgically treated obese patients is associated with a fall in plasma insulin concentrations and suggested that this is initially due to increased fractional hepatic extraction of insulin and only later, with further weight loss, to a reduction in pancreatic insulin secretion. The hyperinsulinaemia of obesity is, however, rapidly reversed by caloric restriction before there is any significant change in body weight. 1. 3.4 The weight reduction in the present group of obese patients was small and we suggest, therefore, that it was the reduction in energy intake, rather than weight loss per se, that caused the increase in the fractional hepatic extraction of insulin. We speculate that only with prolonged caloric restriction and weight loss does pancreatic secretion itself diminish.
This study illustrates the importance of fractional hepatic extraction of insulin in determining peripheral insulin levels and their alteration by food intake. It is consistent with the suggestion that food not only stimulates insulin secretion but also changes the relative extraction of insulin by the liver. 21 -23 In summary, pancreatic hypersecretion is largely or wholly responsible for the fasting hyperinsulinaemia characteristic of obese subjects. In combination with decreased fractional hepatic extraction of insulin it is also responsible for the hyperinsulinaemic response to feeding observed to occur in obesity. The fall in fasting and stimulated peripheral plasma insulin concen-trations that follows a short period of energy restriction is due to increased extraction ofinsulin by the liver rather than to a reduction in its pancreatic secretion.
